Intranasal Vaccination with a Lipopeptide Containing a Conformationally Constrained Conserved Minimal Peptide, a Universal T Cell Epitope, and a Self-Adjuvanting Lipid Protects Mice from Group A Streptococcus Challenge and Reduces Throat Colonization

Batzloff, Michael R.; Hartas, Jon; Weiguang Zeng; Jackson, David C.; Good, Michael F.
August 2006
Journal of Infectious Diseases;8/1/2006, Vol. 194 Issue 3, p325
Academic Journal
Infection with group A streptococcus (GAS) may result in a number of human diseases, including potentially life-threatening postinfectious sequelae. In the present study, J14, a conformationally constrained conserved minimal peptide from the M protein, was incorporated into a lipopeptide construct to which a universal T cell epitope and a self-adjuvanting lipid moiety, Pam2Cys, were also attached. We demonstrate that this lipopeptide construct, when administered intranasally (inl) without additional adjuvants, protects outbred mice from lethal respiratory GAS challenge. In addition, the lipopeptide was capable of inducing J14-specific mucosal immunoglobulin A, which coincided with reduced throat colonization after respiratory GAS challenge. These preclinical experiments show that this lipopeptide could form the basis of an antidisease and transmission-blocking inl GAS vaccine.


Related Articles

  • Innovative vaccine targets streptococci. Posey, L. Michael // Pharmacy Today;Nov2005, Vol. 11 Issue 11, p10 

    The article reports on a study that focuses on the safety and immunogenicity of a 26-valent vaccine developed by ID Biomedical Corp. The study was published in the October 15 issue of "Clinical Infectious Diseases." Strep throat is a common childhood infection caused by group A streptococcus...

  • FDA safety alert on GBS antigen screening.  // American Family Physician;7/1/1997, Vol. 56 Issue 1, p284 

    Offers a look at the guidelines for the use of test kits to detect the group B streptococcal (GBS) antigen as issued by the United States Food and Drug Adminstration. GBS antigen test use in maternity patients and infants.

  • Peptide epitope mapping in vaccine development: Introduction. Castric, P A; Cassels, F J // Journal of Industrial Microbiology & Biotechnology;Jul97, Vol. 19 Issue 1, p56 

    Protection from infectious disease by the host immune response requires specific molecular recognition of unique antigenic determinants of a given pathogen. An epitope is an antigenic determinant which: 1) specifically stimulates the immune response (either B or T cell mediated); and 2) is acted...

  • Precise score for the prediction of peptides cleaved by the proteasome. Ido Ginodi; Tal Vider-Shalit; Lea Tsaban; Yoram Louzoun // Bioinformatics;Feb2008, Vol. 24 Issue 4, p477 

    Motivation: An 8–10mer can become a cytotoxic T lymphocyte epitope only if it is cleaved by the proteasome, transported by TAP and presented by MHC-I molecules. Thus most of the epitopes presented to cytotoxic T cells in the context of MHC-I molecules are products of intracellular...

  • Increased Antigen Specific T Cell Numbers in the Absence of Altered Migration or Division Rates as a Result of Mucosal Cholera Toxin Administration. Kaparakis-Liaskos, Maria; Tate, Michelle D.; Price, Jason D.; Pearse, Martin; Wijburg, Odilia L. C. // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Cholera toxin (CT) is a mucosal adjuvant capable of inducing strong immune responses to co-administered antigens following oral or intranasal immunization of mice. To date, the direct effect of CT on antigen-specific CD4+ T cell migration and proliferation profiles in vivo is not well...

  • Evaluation of Nigrostriatal Neurodegeneration and Neuroinflammation Following Repeated Intranasal 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration in Mice, an Experimental Model of Parkinson's Disease. Tristão, Fabrine; Amar, Majid; Latrous, Ines; Del-Bel, Elaine; Prediger, Rui; Raisman-Vozari, Rita // Neurotoxicity Research;Jan2014, Vol. 25 Issue 1, p24 

    Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting approximately 1 % of the population older than 60 years. The administration of the proneurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice is the most widely used approach to elucidate the...

  • Prevention or Early Cure of Type 1 Diabetes by Intranasal Administration of Gliadin in NOD Mice. Funda, David P.; Fundova, Petra; Hansen, Axel Kornerup; Buschard, Karsten // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Induction of long-term tolerance to β-cell autoantigens has been investigated both in animal models and in human type 1 diabetes (T1D) in order to prevent the disease. As regards external compounds, the dietary plant protein fraction has been associated with high penetrance of the disease,...

  • C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cells. De Groot, Anne S; Moise, Leonard; Ross, Ted M; Levitz, Lauren; Messitt, Timothy J; Tassone, Ryan; Boyle, Christine M; Vincelli, Amber J; Martin, William; Knopf, Paul M // Immunology & Cell Biology;Feb2015, Vol. 93 Issue 2, p189 

    Complement fragment C3d covalently attached to antigens enhances immune responses, particularly for antigens lacking T-cell epitopes. Enhancement has been attributed to receptor cross-linking between complement receptor CR2 (CD21) and polysaccharide antigen to surface IgM on naïve B cells....

  • Killing of Targets by CD8+ T Cells in the Mouse Spleen Follows the Law of Mass Action. Ganusov, Vitaly V.; Barber, Daniel L.; De Boer, Rob J. // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    It has been difficult to correlate the quality of T cell responses with protection against viral infections. To investigate the relationship between efficacy and magnitude of T cell responses, we quantify the rate at which individual CD8+ effector and memory T cells kill target cells in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics